APA (7th ed.) Citation

Correll, C., Burciu, A., Bansal, A., Dennos, A., Narayanswamy, D., Aubrun, E., . . . Amarilyo, G. (2025). Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. Pediatric Rheumatology, 23(1), 1. https://doi.org/10.1186/s12969-025-01144-w

Chicago Style (17th ed.) Citation

Correll, Colleen, et al. "Long-term Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: 5-year Results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry." Pediatric Rheumatology 23, no. 1 (2025): 1. https://doi.org/10.1186/s12969-025-01144-w.

MLA (9th ed.) Citation

Correll, Colleen, et al. "Long-term Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: 5-year Results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry." Pediatric Rheumatology, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12969-025-01144-w.